Saturday, October 20, 2007

Innovative Breast Reconstruction at St. Mary’s Medical Center

Microsurgical Procedure to Use Patient’s Own Tissue to Construct New Breasts


SAN FRANCISCO--(BUSINESS WIRE)--The skilled plastic surgeons at St. Mary’s Medical Center now offer a new breast reconstruction procedure called Deep Inferior Epigastric Artery Perforation (DIEP) flap. According to Dr. Charles Lee, director of microsurgery at St. Mary’s, an upcoming surgery on November 4 will be the first time a double DIEP procedure will be performed at St. Mary’s Medical Center.


This microsurgery procedure is a significant improvement because it allows surgeons to rebuild breast tissue using the patient’s own skin, fat and blood vessels while preserving the abdominal muscle, which is commonly used in other types of flaps.


“Performing reconstruction with the patient’s own tissue offers many advantages,” said Dr. Lee. “Microsurgery means a faster recovery and the breast will look and feel more natural than with implants.”


October is National Breast Cancer Awareness Month. According to the American Breast Cancer Foundation, more than 1.6 million breast cancer survivors are alive in the U.S. today. According to the American Society of Plastic Surgeons, more than 56,000 breast reconstructive surgeries were performed in 2006. DIEP flap procedures accounted for more than 3,500 of them. This is almost double the 1,909 DIEP reconstructions performed in 2005.


“Dr. Lee is one of a select number of plastic surgeons in the country performing this kind of specialized microsurgery,” said Ken Steele, president of St. Mary’s Medical Center. “St. Mary’s has been at the forefront of medical innovation in San Francisco for 150 years and we’re proud that our surgeons are continuing that tradition.”


About St. Mary’s Medical Center


For 150 years, St. Mary’s Medical Center has provided the Bay Area with compassionate, personalized care combined with the latest advances in medical care and cutting-edge technology.


St. Mary’s is a full-service acute care facility with more than 575 physicians and 1,100 employees who provide high-quality and affordable health care services to the Bay Area community. Home to advanced medical practices, such as the nation’s first digital cardiac catheterization laboratory, pioneering spine surgery and comprehensive rehabilitation, St. Mary’s Medical Center is one of San Francisco’s leading hospitals, offering patients a full range of outpatient and inpatient services delivered with the human touch. For more information, please call (415) 668-1000 or visit http://www.stmarysmedicalcenter.org.
Contacts


Mortar
Jamie Fishler, 415-772-9907 ext. 117 (Media)
jamie@mortarpr.com

Abraxis BioScience Receives a Positive Opinion in Europe from the CHMP for the Approval of ABRAXANE for the Treatment of Metastatic Breast Cancer

The Company Begins Establishing Its European Infrastructure to Prepare for the Launch of ABRAXANE in Europe


LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that ABRAXANE® powder for suspension for infusion (an albumin-bound nanoparticle formulation of paclitaxel), has received a positive opinion in favor of approval from the European Committee for Human Medicinal Products (CHMP) for the treatment of metastatic breast cancer in women who have failed therapy in the first-line setting. The CHMP positive opinion was based on the clinical trial data that supported the approval of ABRAXANE in the United States and Canada. In that trial, ABRAXANE demonstrated significant superiority in the clinical endpoints of response rate, progression free survival and survival when compared with Taxol® in the proposed indication in metastatic breast cancer.


“We are pleased that the CHMP has recommended approval of ABRAXANE for the treatment of metastatic breast cancer and look forward to receiving the final approval over the next few months and establishing our presence in Europe,” said Patrick Soon-Shiong, M.D., chairman and chief executive officer of Abraxis BioScience. “More importantly, we believe this positive opinion is an important step in offering women diagnosed with breast cancer across Europe a more effective, convenient and well-tolerated alternative to solvent-based formulations of paclitaxel.”


The positive opinion from the full scientific panel was based on the review of a marketing authorization application (MAA) using the centralized registration procedure. Abraxis BioScience has now begun the process of establishing a European infrastructure for the commercialization of ABRAXANE across Europe. The launch of ABRAXANE in Europe by Abraxis will initially focus on the United Kingdom, France, Spain, Italy and Germany.


The positive opinion from the CHMP is the final step before formal approval to market ABRAXANE in Europe. A formal decision by the European Commission on marketing authorization is expected within the next three to four months.


About ABRAXANE


The U.S. Food and Drug Administration approved ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in January 2005 for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within six months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. The most serious adverse events associated with ABRAXANE in the randomized metastatic breast cancer study for which FDA approval was based included neutropenia, anemia, infections, sensory neuropathy, nausea, vomiting and myalgia/arthralgia. Other common adverse reactions included anemia, asthenia, diarrhea, ocular/visual disturbances, fluid retention, alopecia, hepatic dysfunction, mucositis and renal dysfunction. For the full prescribing information for ABRAXANE, please visit www.abraxane.com.


About Abraxis BioScience, Inc.


Abraxis BioScience, Inc. is an integrated global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures and markets one of the broadest portfolios of injectable products and leverages revolutionary technology such as its nab™ platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases. The first FDA approved product to use this nab platform, ABRAXANE®, was launched in 2005 for the treatment of metastatic breast cancer. Abraxis trades on the Nasdaq Global Market under the symbol ABBI. For more information about the company and its products, please visit www.abraxisbio.com.


Forward-Looking Statement


The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the approval and launch of Abraxane in Europe. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the market acceptance of Abraxane in Europe, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties. Additional relevant information concerning risks can be found in Abraxis BioScience’s Form 10-K for the year ended December 31, 2006 and other documents it has filed with the Securities and Exchange Commission.


The information contained in this press release is as of the date of this release. Abraxis assumes no obligations to update any forward-looking statements contained in this press release as the result of new information or future events or developments.


Taxol® is a registered trademark of Bristol-Myers Squibb Company.


Contacts


Investors and Media:
Abraxis BioScience, Inc.
Christine Cassiano, 310-633-9495

Press Briefing by Assistant to the President and Chief of Staff to the First Lady Anita McBride and Deputy Assistant to the President and Deputy National Security Advisor Elliott Abrams on the First Lady's Trip to the Middle East

WASHINGTON--(BUSINESS WIRE)--


James S. Brady Press Briefing Room


10:00 A.M. EDT


MS. McBRIDE: I wanted a chance to talk to you a little bit about Mrs. Bush’s trip to the Middle East. She’ll be leaving tomorrow night and will be gone for a week. The schedules are being passed out to you right now. I will preface this by saying we did not intend for the entire book to be printed in pink. I think the print shop was being very kind to highlight breast cancer awareness.


But anyway, the pillar of the trip to the Middle East is really to highlight the accomplishments of the Middle East Partnership Initiative programs of the State Department, a public diplomacy effort of the State Department. Specifically, we will be visiting a number of programs in countries that have launched the partnership already of the U.S.-Middle East Partnership for Breast Cancer Awareness and Research.


Many of you may know, Mrs. Bush has a personal history with breast cancer. Both her mother and her grandmother had breast cancer. She was one of the early, early volunteers with the Komen Foundation at its start 25 years ago in Texas, with her friend, Nancy Brinker. She helped to launch this partnership, the Breast Cancer Awareness Partnership last June 2006 here in Washington, when the program was announced.


The first two countries of the partnership were the UAE and Jordan. We will be traveling there. That’s the first stop on our visit. You can see from your schedule, we will go to Abu Dhabi, and we will visit a Pink Majlis, it’s called -- it’s a "place of sitting." It’s a very culturally accepted and sensitive place where women can come together and talk about issues that are important to them. Specifically in this case -- and everything is in pink, is what I’m told, of this site, where they get information, awareness, education on breast cancer, specifically early detection.


One point to raise with all of you is that breast cancer still continues to be in our country the leading cause of death amongst women. In the Mideast specifically, it is detected at a much later stage, usually at stage three and four; 70 percent of the cases are late stage.


We are trying to export in this program the 25 years of experience and background that we have had in raising awareness and education and early detection. This is one of the beauties of this partnership.


And I should back up to tell you who the members of the partnership are: of course, our government through the State Department, but also two of the programs that are well known and well respected around the world -- the Komen Foundation, for its advocacy and awareness and education efforts, and M.D. Anderson, one of our leading American hospitals in research and treatment. They make up the partnership that then is linked with other countries that want to take on this program and benefit from our experience.


So in Abu Dhabi, again, we will have this meeting with women to come and learn about breast cancer awareness, also meet with people who have had breast cancer, so people can learn from each other in this situation. Also then, we will go on -- have a meeting with Sheikha Fatima. Sheikha Fatima will host Mrs. Bush for lunch. Sheikha Fatima has been very important to this partnership because it is through her efforts to help raise awareness in the UAE.


We’ll go on to Dubai. One of the interesting things there -- here is a workplace awareness program where American companies and Emirati companies have come together to launch a workplace awareness program, an education program, which is really an important first step for people to become aware of breast cancer.


When we leave Dubai we will go to Saudi Arabia. And here is where Mrs. Bush will launch the partnership officially in Saudi Arabia. Saudi Arabia becomes the third country to take on the Breast Cancer Partnership program. Mrs. Bush will meet with King Abdullah as well; he will host her. He is interested in hearing about this program and about the work of the U.S. partners with the Saudi partners in breast cancer. Mrs. Bush -- actually we’ll be meeting with the King in Jeddah. We go on to Jeddah, where she will meet with him.


She also will do -- and the next day we will go on to Kuwait. This is not a Breast Cancer Partnership country. However, we are in the region; Kuwait is a great ally. It’s an opportunity to showcase some of the other MEPI programs that are successful in Kuwait, particularly a political women’s leaders meeting that we will have with women who have run for parliament, that are active in political participation. I think many of you know Kuwait women earned suffrage there in 2005, and 2006 was the first opportunity women had to run for office.


She’ll also attend an event where we can showcase the progress of the Micro Access Scholarship program, which is another very effective MEPI program. And she’ll meet with teachers, teachers like Mrs. Bush herself. And these teachers are there to help learn how to identify students that could partake in this scholarship program. And this is like an exchange program where they come and work here or learn here in the United States.


She’ll also meet with the Amir Al-Sabah while we are in Kuwait. She’ll have a meeting with the troops as well. She’ll meet with -- of course, we have large bases there in Kuwait. She’ll be able to meet with troops who are transiting through Kuwait after being deployed, but also meet with -- I’m not sure of the number, but I think it’s well over a thousand members of our troops that she’ll be able to speak with. And this is something she typically does.


She will go on to Jordan where King Abdullah will meet with her and host her for lunch before she goes on to the King Hussein Medical Center, which, there she’ll be able to unveil with -- along with King Hussein’s two daughters, who have been very active in the King Hussein Cancer Center, which is very well known for pediatric oncology. But they are very anxious to take on this partnership with M.D. Anderson and the Komen Foundation to raise awareness of breast cancer.


And when I met with the Princesses a couple of weeks ago when they were here, they were explaining to us how there is a very high incidence of young women, women that are 30 years old, that have high incidence of breast cancer.


So they are very anxious to take on this partnership, and they will unveil with Mrs. Bush a breast cancer screening center in Jordan on the grounds of the King Hussein medical hospital.


And then from -- after that, we’ll go on to see an important cultural historical site in Petra, which is a UNESCO protected cultural site. And you know, many of you know Mrs. Bush is the honorary ambassador for UNESCO’s Decade of Literacy. So we try to show support for their programs wherever we can.


I think the important thing to note, really, about this is this is a real model public-private partnership between the U.S. government and private organizations that really take the tremendous amount of expertise that we have learned and able to showcase that and make it an example of how we can help and partner with something we’ve learned a great deal about in another country.


This is Mrs. Bush’s second trip to the Middle East this term. This is one that we feel very strongly about being able to show the progress in just a short time, in a year’s time since this partnership was announced last June. So we’re eager to see what they’ve been able to do, and also we’re eager to be able to announce that the partnership will be expanded to three other countries. And we’ll be making that announcement while we are in Jordan.


I don’t know if you have any other questions specific to the trip. Sure, Caren.


Q You’ve outlined an agenda that has an overriding theme of breast cancer awareness, but obviously this trip comes at a month before the Mideast conference here and Bush’s meeting with several heads of state. How much of it is a diplomatic trip, and will she be discussing any of the themes, any of the substance ahead of that conference?


MS. McBRIDE: Well, it’s not ahead of that conference, and actually, I can say, we began planning for this trip back in June when the anniversary of the announcement and the launch of the partnership. We asked the State Department what has been the progress since that year’s announcement, and when they presented to us a proposal of the various aspects of the program that have been successful in UAE and Jordan, we made a decision then of being able to travel this fall, before the year was out, to be able to see it first hand. We also knew the State Department was getting ready to look at expanding the program, and we wanted to be able to take that good news directly.


So there was no link between the planning of this trip and the event that the President will host later this fall. But obviously, this is a diplomatic effort and a diplomatic trip. This is a shining example of our public diplomacy efforts from the State Department. So although they are not linked, certainly the timing is probably very good.


Q Is she going to get into any issues of Mideast peace, or --


MS. McBRIDE: Well, I’m sure that these are not the issues that she will raise. If these leaders, of course, raise with her, of course she’ll show great support on behalf of the President. She’s a great ambassador for the country and a great ambassador for the President to support any and all of his initiatives and the things that he cares about, certainly. I mean, it’s a sign of great respect that the leaders of each of these countries do want to meet with her, have asked to meet with her, are very aware of her program. It’s also a great sign that they know why she’s coming, and she’s able to talk about these issues, that even in our own country 25 years ago we really weren’t talking about it. So it’s a great sign that we’re able to discuss these things there. Thanks for asking that, though.


Q Thank you. I’d like to ask about two countries she is not visiting. First of all, why is she not going to Israel?


MS. McBRIDE: We were in Israel two years ago, Mrs. Bush did a visit.


Q Why isn’t she going on this trip? I understand there’s a lot of angst in Israel that she’s going to all of these Arab countries and not coming there.


MS. McBRIDE: I’m not aware of the angst, and again --


Q It’s in their media.


MS. McBRIDE: Because of the pillar of this trip, which we did say is breast cancer. Israel is not one of the countries that was in the breast cancer partnership. So there would have not been --


Q Neither were a lot of the other countries. You have said that some of the countries --


MS. McBRIDE: All of these are.


Q Well, you said that -- you mentioned -- you said there --


MS. McBRIDE: Kuwait, there are MEPI --


Q You said three are joining.


MS. McBRIDE: No, two already have the partnership. UAE established the partnership in October of ’06; Jordan established the partnership in March of 2007. The Saudi partnership will be launched with the unveiling of the breast cancer screening center when we are there on Wednesday. So those three already are established partners with the breast cancer initiative.


Q So the stated reason that you’re not going to Israel is that she’s been there before, and then --


MS. McBRIDE: As I said at the beginning, the pillar of this trip is to show support and show accomplishments of the Middle East Partnership Initiative programs. So the breast cancer program is one Mrs. Bush specifically announced and launched in June of 2006. The idea to go to the region at this time is to show the accomplishments of that program and MEPI-related programs, which there are two in Kuwait that we will be seeing, the Micro Access Scholarship program, with teachers.


Q Given all of the medical research that goes on Israel, why isn’t it part of this consortium?


MS. McBRIDE: It may be part of the consortium. It may be expanded. This is a brand new program, just started in June of last year with targeted countries where there were high incidences of cancer, particularly at a very early rate. The hope is that this gets expanded throughout the broader Middle East. That’s the name of it -- Middle East Partnership Initiative. It’s starting in one place and will continue to grow. I think there’s great hopes that it is expanded throughout the region, no question.


Q And then the other country I wanted to ask you about obviously is Iraq. What are her concerns -- I guess for obvious reasons she’s not going there, but what are her concerns about women’s issues there?


MS. McBRIDE: Absolutely, very concerned about women’s health issues in Iraq and Afghanistan. We meet with women that travel here from both Afghanistan and Iraq all the time that are part of the international visitors program; specifically we have been focused a great deal on education and access to education for women and girls. And again, I think there is a great hope, honestly, that these programs can be expanded throughout the broader Middle East, no question about it.


Yes.


Q After the tsunami, with America’s efforts in Southeast Asia, the image has improved. Do you think that with the First Lady going on a (inaudible) program like this in the Middle East, it will help to improve America’s image? Considering that actually she is quite popular, more than the President.


MS. McBRIDE: Well, I think, again, all of these are programs and initiatives of the President and his administration. Mrs. Bush has the ability and the luxury, frankly, to be able to choose from issues that are important to the President and his administration, to be able to advocate for them. This is one where we felt was perfect for Mrs. Bush to do. She has a long time standing in history with women’s health issues, specifically breast cancer, because of the incidences in her own family. It brings a very private and human face to this to be able to discuss this issue outside of our country and really be able to export -- again, this is a wonderful example of what Americans have been able to do when both the public and private entities come together and use the 25 years of research, 25 years of education, advocacy, awareness, and be able to export this overseas.


But again, a partnership means having a willing partner on the other side that wants this and wants to be able to collaborate and be able to learn effectively from everything that we have learned over these 25 years.


But part of this, too, is for our American institutions -- this is as good for them as it is for us, because -- specifically for M.D. Anderson. They are a well-known research facility. But they will be able to look at this statistic of why so many young women, age 30 and younger, are getting breast cancer, and be able to work with their counterparts, their medical counterparts, and be able to research that, and hopefully be able to reverse that.


So it is a perfect partnership because it is a great face of what Americans are able to do and take our expertise. But we also intend to learn from where we’re going.


Yes, sir.


Q First Lady is not visiting Egypt as well. We all remember last time she visited Egypt, she praised democratic reforms and decisions by President Mubarak to hold multiparty elections. Does she feel frustrated now or disappointed especially that this White House, as recently as last month, criticized Mubarak for a crackdown on human rights activists and (inaudible) threats?


MS. McBRIDE: Is she disappointed? I think, again, as you know, Mrs. Bush did travel to Egypt, Israel, as part of Mideast trip that we took in 2005. And of course, Mrs. Bush is hoping for peace in the region, as well as the President does.


I don’t know -- again, that is not a part of what we’re traveling there for. I don’t know if Elliott wants to respond to that.


Yes, sir.


Q Are you able to specify the dates you will be in Kuwait?


MS. McBRIDE: Sure. I think I’ll give you the exact date, because we have the schedule that’s going around in your little pink folders there. I think that we are in Kuwait on the 24th of October.


Q Can you touch on some of the topics you’re going to discuss with the Amir, and also with the women parliamentary candidates?


MS. McBRIDE: Actually, the women parliamentary candidates, what they want to show her, there’s a documentary that’s been done about their efforts to campaign and to run for office. She will see a short portion of that documentary, chronicling how they ran for office. She’ll be able to talk with them about -- I mean, they’re interested, too, in her efforts in campaigning here in the United States. When women gained suffrage there in 2005, I remember at that time meeting at the Kuwaiti embassy one of the women that was going to be running for office, and very excited. And she had said back then it would -- we know how much Mrs. Bush has done to help her husband run for President, we know how many -- they knew statistics on how many of our women are members of Congress. And they were hoping someday if she was ever able to come and show her support for women democracy leaders, they really would welcome it. And this is a chance for us to do it.


Now with the Amir, the Amir knew of her schedule and asked to see her. Again, a great sign, I think, of friendship between our two countries, long-time friendship between our two countries. But I don’t know what’s on his agenda to talk to her about.


Yes, Sheryl.


Q This may be an Elliott question, but have all the countries that she’s visiting agreed to participate in the Middle East conference?


MS. McBRIDE: That I don’t know.


MR. ABRAMS: No invitations have been issued yet to any country for the conference.


Q Okay. And Anita, you said that the timing is fortuitous, it wasn’t linked, but what, in your opinion, can Mrs. Bush do while she’s there to make this conference a successful one? Maybe that’s an Elliott question.


MS. McBRIDE: I’m not sure -- again, the topics aren’t linked, but obviously, the relationship between all the countries is important. This is one area where she has expertise, and is able to talk about a global health issue that she’s involved in. She’s not going to be talking about the issues that are going to be at the conference.


Okay? Thank you.


END 10:23 A.M. EDT
Contacts


White House Press Office
1-202-456-2580


Pink Ribbon Girls, Breast Cancer Support Group for Women, Receives Donation

Three sisters who survived breast cancer raise money for the Pink Ribbon Girls.


Cincinnati, OH (PRWEB) October 15, 2007 -- The Pink Ribbon Girls, a breast cancer support group geared towards young women, were recently the recipient of a donation, thanks to three sisters who are all breast cancer survivors.


Laughter is the best medicine, so I began to share this vision with others
Karen Sacksteder, of Sacksteder’s Interiors, and her two sisters, Linda Nixon and Connie Acra, were all diagnosed with breast cancer within six months of each other. Connie and Linda underwent double mastectomies. Karen had chemotherapy treatments and she lost all of her hair.


The sisters wanted to give back to the group that helped them through their breast cancer diagnosis - the Pink Ribbon Girls. The sisters used humor as part of their fundraising strategy by selling Bodacious Boas. Karen had found that these bright, fluffy, pink boas have helped take the edge off during her chemotherapy treatments and she celebrated the end of a difficult and terrifying treatment with pink boa parties.


"Laughter is the best medicine, so I began to share this vision with others," Karen said.


The pink Bodacious Boas have brought laughter through tears and strength through pain for many a cancer patient and their families. They share their story with you to give courage to others. For more information, please visit www.sackstedersinteriors.com.


About Karen Sacksteder:
As CEO and owner of Sacksteder’s Interiors and Design Group for over 21 years, Karen recently became a widow. Her husband of 30 years died just one year prior to her diagnosis. As an upcoming author and a cancer survivor, Karen has a book, due in November 2008, on the humorous side of breast cancer. Part of the proceeds of her new book, "Vivacious Vivian, The Wig That Helped A Girl Through Breast Cancer," will go to the Pink Ribbon Girls. Karen’s business, "Sacksteders Design Group was recently certified as a Women’s Business Enterprise for the National and the Southeast Council for minority, women-owned businesses. Karen has been featured by the Wall Street Journal and Redbook Magazine.


About Pink Ribbon Girls:
Pink Ribbon Girls are young breast cancer survivors, who are encouraged by their shared experiences to educate and inspire others to grow and live beyond breast cancer.


Contact:
Kathy Smith
859-801-7185/ 859-689-5205
kathyasmith @ fuse.net
fax:859-689-7244


###

Daryn Kagan to Mark Breast Cancer Awareness Month With Weeklong Special Series on DarynKagan.com -- "Shop Daryn" Opens With Proceeds to Benefit Breast Cancer Awareness

Daryn Kagan, creator and host of DarynKagan.com, marks Breast Cancer Awareness Month with a week long series of hopeful news stories of women who inspire others through their breast cancer experiences. "Shop Daryn," the exclusive online store where Internet users can purchase various DarynKagan.com items, launches today at DarynKagan.com, and a portion of all proceeds will benefit breast cancer organizations. Daryn, the former CNN news anchor, has been active in promoting the message of early prevention and detection since her Mother, Phyllis Kagan, was diagnosed with breast cancer in 2003. An early detection success story, Phyllis will celebrate the 5th anniversary of her survivorship in Feb. 2008.
Through DarynKagan.com I ’ll continue to promote the message of early prevention and detection, and share the inspiring stories of these incredible women who truly


(PRWEB) October 12, 2007 -- DarynKagan.com will mark Breast Cancer Awareness Month with a weeklong series beginning October 15 that will include exclusive DarynKagan.com stories featuring women who inspire others through their journeys with breast cancer.


News Image


Additionally, SHOP DARYN, Daryn’s online store that features numerous DarynKagan.com products, has launched at http://www.DarynKagan.com, and a portion of all proceeds will benefit several breast cancer organizations.


Daryn is dedicated to increasing awareness of breast cancer issues as her mother, Phyllis, is a breast cancer survivor, and an early detection success story. Since 2003, they have joined forces to discuss their experiences as a family dealing with a breast cancer diagnosis through several media outlets, including CNN and Self Magazine.


I consider myself part of the breast cancer family, said Daryn. "Through DarynKagan.com I ’ll continue to promote the message of early prevention and detection, and share the inspiring stories of these incredible women who truly "Show the World What’s Possible" with their acts of courage and commitment."


This special series will include:


Breastless In The City - Author Cathy Bueti shares her inspiring story of looking for love while a young breast cancer patient in New York. How does a young woman continue to date while going through breast cancer surgery, radiation, and chemotherapy? Cathy shares her story, and the love she did find, with humor, tears, and courage.


Feel Your Boobies - While Leigh Hurst was going through cancer treatment after finding a lump in her breast during a self-examination, she encouraged those around her to do their own self-exams. Leigh created t-shirts for her friends that said, "Feel Your Boobies," because she strongly believed that early detection saved her life. What began as a simple gift for a group of friends has evolved into an international non-profit organization to make women more breast aware.


Pink-Link.org - Vicki Tashman shares her journey of trying to find a support group as she went through breast cancer treatment. When she did not find what she wanted -- another woman who had the same type of breast cancer and the same type of treatment -- Vicki decided to create an online matching service for breast cancer patients, survivors, and caretakers.


UptownLiz.com - In honor of her sister, Liz, who died last year from breast cancer before her 30th birthday, Ramona Russell started an online business that promotes products from companies whose proceeds directly give back to charitable organizations. Internet users can search by cause or product, with the knowledge that each purchase will make a difference.


DarynKagan.com is the exclusive online channel for Daryn Kagan’s unique brand of inspirational news stories, and the base of her media company that provides hopeful and inspirational news content across numerous platforms. DarynKagan.com has become a daily destination for thousands of Internet users who seek hopeful news stories that "Show the World What’s Possible." Before creating DarynKagan.com, Daryn served as a news anchor and reporter for CNN from 1994-2006. She traveled the world to report on breaking news stories and events, including live from the Middle East during the war in Iraq, live from the red carpet at numerous Academy Award ceremonies in Los Angeles, and to several countries in Africa with musician and U2 band member Bono to report on famine and AIDS. Daryn’s first book, What’s Possible! Creating Possibilities Beyond Life’s 5 Greatest Obstacles, will be published by Meredith Corp.’s book division, Meredith Books, in 2008.



DarynKagan Media Contact:
Paul Schur 202-549-5882 Paul@PaulSchur.com PaulSchur.com


###

At Home Breast Cancer Cure Finally Made Public

The number one reason for breast cancer spreading around the world is the way we select, prepare (cook) and eat our food.


Newton, MA (PRWEB) October 17, 2007 -- Since October has been named Breast Cancer month, let’s declare, ’Peace with Breast Cancer.’ David Snieckus of Newton, MA., Macrobiotic Counselor and Chef for over 30 years says, "Instead of bombarding the tumors with radiation or chemotherapy or invading woman’s bodies with a knife, let’s begin a more gentle and peaceful way. Let’s start by being grateful for our cancer as a messenger for us to address its cause and change our lifestyles!"


We can prevent and actually reverse cancer without doctors and their drugs by strengthening our immune systems! This begins right in our own kitchens with a change in our diets!" NOTE: TIME magazine, Oct. 15th 2007 by Kathleen Kingsbury said that the American diet is one reason breast cancer is spreading around the world.


Cooking or preparing natural whole plant-based foods in our own kitchens is the one simple thing each individual can do every day to prevent and even reverse breast cancer and optimize health and well-being. As we become proficient at selecting, balancing, and preparing such foods, we become our own doctors, our own healers, and our own "health care providers". Furthermore, learning about the best and healthiest foods to eat is the best healthcare reform. As we optimize our health through the food we eat, we become part of the solution in reducing healthcare costs.


David Snieckus, through one-on-one consultations and teachings about ancient principles and the proper selection, cooking and eating of natural whole plant-based foods, can help you launch your path to optimum health.


Mr. Snieckus’ vision is every kitchen a wellness center and one peaceful and healthy world. He invites and welcomes everyone and anyone to be a part of that vision.


For more information, call for the no-obligation program outline and references at 617-964-2951, or visit: www.davidsnieckus.com.


David Snieckus, a graduate of the world renowned Kushi Institute, is the primary sponsor of House Bill 2841 which calls for the removal of the tax exemption of processed food.


David Snieckus
99 Crescent Street
Newton, MA 02466
617-964-2951
info @ davidsnieckus.com
www.davidsnieckus.com

Extent of breast cancer key for predicting spread

powered by Sphere Sphere


NEW YORK (Reuters Health) - After treatment for breast cancer, women are commonly classified as either being in remission or not, depending on whether cancer is still present. New research suggests, however, that in predicting whether the cancer will spread to distant body sites, it is important to determine not simply if there is cancer, but how much.


As reported in the Journal of Clinical Oncology, Dr. W. Fraser Symmans from the University of Texas M. D. Anderson Cancer Center, Houston, and associates assessed the amount of cancer present in 241 patients who had been treated with chemotherapy.


To do this, the researchers developed a scoring system called the residual cancer burden, or RCB, that quantified rather than classified the cancer.


Each unit of increase in the RCB score was associated with a 94 percent increase in the risk of cancer spreading to a distant body site.


The researchers believe that use of the RCB score will allow doctors to better predict which women will do worse after being treated with chemotherapy for breast cancer.


SOURCE: Journal of Clinical Oncology, October 1, 2007.

Exercise Can Reduce Breast Cancer Risk: Fitness Expert David Berger Suggests First Steps in Fitness Program

A woman’s risk for breast cancer can be reduced through regular exercise, which lowers hormone levels. Fitness guru David Berger recommends beginning an exercise regimen during October, which is Breast Cancer Awareness month. Berger has developed a free, downloadable Exercast of three exercises that are an excellent beginning for any new fitness routine.


Wilmington, DE (PRWEB) October 20, 2007 -- Breast Cancer Awareness Month, recognized each October, is an ideal time for women to take a step toward breast cancer prevention by starting an exercise program, says Fitness Expert David Berger, developer of the Number One Me™ personal coaching system. Studies have proven that exercise reduces breast cancer risk because it can decrease hormone levels, especially in young women.


"With the increased national attention on breast cancer, it is a great time to get the message out that women can take a personal stand against breast cancer by exercising and lowering their risks," Berger says.


In fact, physical activity is likely to reduce personal risk for all cancers. Research shows that about one-third of all cancer deaths are related to dietary factors and lack of physical activity in adulthood. The American Cancer Society suggests 45 to 60 minutes of exercise five or more days a week.


Berger has developed a series of exercises and a free downloadable Exercast to make it easy for women who want to start an exercise routine during Breast Cancer Awareness Month--or at any time. The Exercast is available at http://www.numberoneme.com/images/pinkribbon.wmv


When you’ve mastered these routines, visit www.numberoneme.com to learn more about building an exercise program for LIFE.


About David Berger: At the age of 18, weighing over 250 pounds with a 40-inch waist and smoking a pack of cigarettes a day, David Berger struggled to climb a single flight of stairs. David’s journey to better health began when he quit smoking. He also decided that he would immediately begin eating healthier and exercising, climbing a single flight of stairs a day and adding another flight each week. He also started performing calisthenic exercises. Through his commitment to his consistent and progressive approach, he lost over 88 pounds and 6 inches from his waist within one year. David went on to earn a degree in Kinesiology from West Chester University and launch Progressive Fitness Coaching and now the NUMBER ONE ME! personal coaching DVD.


About Number One Me™ at www.numberoneme.com: Increase your core strength, balance, endurance and flexibility…Be Fit For Life. David Berger’s NUMBER ONE ME--Personal Coaching for Personal Best! Learn to effectively use the single greatest piece of exercise equipment ever created…your body. Over 45 calisthenic exercises instructed for you in three levels of progression: beginner, intermediate, and advanced. Exercise at your convenience and in the comfort of your home with peak-performance coach David Berger. No more excuses.


###

Sarasota Business Woman Walks for Cause

Sarasota business owner, Elsie Gilmore, raised $250 and participated in the October 13th Making Strides Against Breast Cancer 3-mile walk.


Sarasota, FL (PRWEB) October 20, 2007 -- On Saturday, October 13, 2007, Elsie Gilmore, owner of True Green Studios, a website design and development studio located in Sarasota, Florida, participated in the American Cancer Society’s Making Strides Against Breast Cancer 3-mile walk. The walk was held at the polo grounds, located in Lakewood Ranch, with approximately 4,000 walkers participating. $346,000 was raised for breast cancer research.


Along with numerous individual donations, Ms. Gilmore received generous donations from the following businesses: Felicia Rothberg - Graphic Designer (www.feliciar.com), Drycleaning To Go (www.drytogo.com), Hotel Technology Services (www.hoteltechservices.com), and Orthopaedic Center of Southwest Florida (www.orthocenterflorida.com). Thanks to these donors, she was successful in reaching her $250 fundraising goal.


About Making Strides Against Breast Cancer
Since 1993, 3.5 million walkers across the country have raised more than $230 million through Making Strides events to help fight breast cancer. Last year alone, the efforts of dedicated supporters raised more than $40 million nationwide to enable the American Cancer Society to continue fighting breast cancer every day. The donations that are collected enable the American Cancer Society to fund cutting-edge research, provide up-to-date cancer information and education, advocate for all people to have access to critical cancer screenings and follow-up care, and offer free programs to improve the quality of life for patients and their families.


About Elsie Gilmore
In 2003, Ms. Gilmore founded True Green Studios (www.truegreenstudios.com), a full service web design and development studio. Last year she was honored as one of Gulf Coast Business Review’s "40 Under 40", and she recently created the women’s business networking group, Women With Moxie (www.womenwithmoxie.com).


# # #


NET-A-PORTER.COM

NET-A-PORTER.COM Launches Fashion Targets Breast Cancer Worldwide Program With Limited-Edition Ralph Lauren Polo Shirts


NET-A-PORTER.COM, in partnership with The Council of Fashion Designers of America/CFDA Foundation Inc., announces its initiative to raise breast cancer awareness. Limited-edition polo shirts designed by Ralph Lauren are part of the Fashion Targets Breast Cancer Worldwide series of products, which features fashions by some of the world’s leading international designers.


New York, NY (PRWEB) October 16, 2007 -- Limited-edition Ralph Lauren polo shirts are available as part of Fashion Targets Breast Cancer Worldwide (FTBC), an initiative to raise breast cancer awareness recently launched by NET-A-PORTER, in partnership with The Council of Fashion Designers of America/CFDA Foundation Inc. The polo shirts and other products are for sale exclusively at www.net-a-porter.com.


With this year-long initiative, NET-A-PORTER.COM, the world’s leading online luxury retailer, is bringing women all over the world together to raise breast cancer awareness and support a worthy cause.


The NET-A-PORTER and FTBC year-long initiative will feature a series of limited-edition polo shirts designed exclusively by Ralph Lauren. Individuals can buy one now for £55/€80/$75. All net proceeds will be donated to Fashion Targets Breast Cancer ® WORLDWIDE, where they will benefit local breast cancer charities around the world.


Photographer Patrick Demarchelier, creative director David Lipman and five of the world’s hottest supermodels contributed their time and talent to produce the beautiful image used for the Fashion Targets Breast Cancer and NET-A-PORTER initiative. Watch the behind the scenes action from the day of the shoot at http://www.net-a-porter.com/FTBC/FTBehindTheScenes


Visit NET-A-PORTER’s FTBC store featuring need-to-know facts about breast cancer, unique merchandise, as well as behind-the-scenes footage of the FTBC ad campaign, featuring the Ralph Lauren-designed polo shirts worn by top models.


For more information about NET-A-PORTER and Fashion Targets Breast Cancer Worldwide, visit www.net-a-porter.com/FTBC or www.fashiontargetsbreastcancer.org.


Click here to make a difference and buy an FTBC polo shirt: http://www.net-a-porter.com/Shop/Featured-Products/FTBC


About NET-A-PORTER.COM
NET-A-PORTER.COM was launched in June 2000 and has since successfully established itself as the world’s leading global online luxury retailer. Presented in the style of an online fashion magazine, NET-A-PORTER.COM features each season’s key trends, helpful editors’ tips and expert style advice. With luxury packaging, free returns, same day delivery in London, New York City and express delivery to the rest of the world, NET-A-PORTER.COM provides an unparalleled level of service and designer offerings to online shoppers.


For further information please contact the NET-A-PORTER.COM in-house PR team: Emma Paton +44 207 255 4504


# # #

Breast Cancer Deaths Declining In Wisconsin

State officials reported that breast cancer incidence and mortality rates in Wisconsin are declining, but not all racial and ethnic groups are benefiting from advances that lead to improvements in survival. The Wisconsin report reveals a key health disparity between white and African American women, showing that even though white women are more likely to be diagnosed with breast cancer, African American women are more likely to die from breast cancer.


’While the decline in breast cancer incidence and mortality is encouraging, the need for effective and early screening is still very important to women of all ethnic and racial groups,’ said Department of Health and Family Services Secretary Kevin Hayden.


The national decline in reported incidence has been attributed to the sharp drop in women receiving hormone replacement therapy and a recent trend of fewer women getting mammograms. The decline in mortality is largely attributed to earlier detection and improved treatment.


Highlights of the report include:


* In 2004 (the latest year for which figures are available), approximately 3,900 women in Wisconsin were diagnosed with invasive breast cancer, accounting for more than one in three cancers diagnosed in Wisconsin women.


* During 2000-2004, almost two-thirds of breast cancer cases were diagnosed at an early (localized) stage when treatment is most effective.


* Breast cancer incidence varied by racial and ethnic group, with white women having the highest rate and Asian/Pacific Islander women the lowest rate.


* Breast cancer mortality was highest among African American women and lowest among Hispanic women.


* Between 2000 and 2004, the breast cancer mortality rate among Wisconsin women overall decreased by an average of 2.3 percent annually.


* In 2004, some 770 Wisconsin women died from breast cancer, making it second only to lung cancer as a leading cause of cancer death among women in the state.


Breast cancer is detectable at an early stage by mammograms, and many more lives could be saved by taking advantage of regular screening. This is especially critical for those women in populations with higher mortality for breast cancer. Annual mammograms are recommended by the American Cancer Society for women beginning at age 40, and earlier for those women at higher risk (such as those with a family history or genetic predisposition for breast cancer).


The national five-year survival rate for women diagnosed with early-stage breast cancer is 98 percent. In 2000-2004, 62 percent of breast cancer in Wisconsin was detected early.


source : www.emaxhealth.com


Exposure to sunlight may decrease risk of advanced breast cancer

www.chinaview.cn 2007-10-20 00:27:13


A U.S. research team has found that increased exposure to sunlight -- which increases levels of vitamin D in the body -- may decrease the risk of advanced breast cancer, according to a study reported Friday in the latest issue of American Journal of Epidemiology. (File Photo)
WASHINGTON, Oct. 19 (Xinhua) -- A U.S. research team has found that increased exposure to sunlight -- which increases levels of vitamin D in the body -- may decrease the risk of advanced breast cancer, according to a study reported Friday in the latest issue of American Journal of Epidemiology.


The researchers from the Northern California Cancer Center, the University of Southern California, and Wake Forest University found that women with high sun exposure had half the risk of developing advanced breast cancer, which is cancer that has spread beyond the breast, compared to women with low sun exposure. These findings were observed only for women with naturally light skin color.


The fact that this difference occurred only in light skin color group suggests that the effect was due to differences in vitamin Dproduction, said the researchers. And the difference was seen only in women with advanced disease, suggesting that vitamin D may be important in slowing the growth of breast cancer cells.


"We believe that sunlight helps to reduce women’s risk of breast cancer because the body manufactures the active form of vitamin D from exposure to sunlight," said Esther John, lead researcher on the study from the Northern California Cancer Center. "It is possible that these effects were observed only among light-skinned women because sun exposure produces less vitamin D among women with naturally darker pigmentation."


Skin color is an important factor that determines how much vitamin D is produced in the body after sun exposure. Dark-skinned individuals produce up to 10 times less vitamin D than light-skinned individuals for the same amount of time spent in the sun.


These new findings are consistent with previous research by John and colleagues that had shown that women who reported frequent sun exposure had a lower risk of developing breast cancer than women with infrequent sun exposure.


The researchers stressed that sunlight is not the only source of vitamin D, which can be obtained from multivitamins, fatty fish and fortified foods such as milk, certain cereals and fruit juices. Women should not try to reduce their risk of breast cancer by sunbathing because of the risks of sun-induced skin cancer, they said.


"If future studies continue to show reductions in breast cancer risk associated with sun exposure, increasing vitamin D intake from diet and supplements may be the safest solution to achieve adequate levels of vitamin D," said Gary Schwartz, a co-researcher from Wake Forest University.



Editor: Mu Xuequan

Raising breast cancer awareness session held

ISLAMABAD: An information session to promote awareness about breast cancer diagnosis was held on Friday.


The event was held at Islamabad College for Girls, Sector F6/2 and was facilitated by Pink Ribbon Volunteers, a project of Women Empowerment Group and Vision 2015 International.


Pink Ribbon Campaign National Coordinator Omer Aftab said the pink ribbon was an international symbol of support for breast cancer awareness since the last ten years.


He said that citizens were urged to wear pink ribbons every year in October in honour of women who were now courageously fighting the battle against breast cancer.


“The pink ribbon is an emblem of hope for breast cancer sufferers and for everyone who is working to fight this curable disease”, Omer Aftab said.


The principal objective of the Pink Ribbon Campaign, he said, was to create widespread awareness about breast cancer and to promote the understanding and practice of self-diagnosis. It was also an attempt to motivate people to collect funds for campaign execution, he added.


Through a presentation, NORI Hospital Islamabad Consultant Oncologist and Radiotherapy and Oncology Head Dr Kaukab Jabeen highlighted the importance of the self-examination of breasts and regular mammography in the early detection of breast cancer. She also underlined the need for a healthy lifestyle in the prevention of breast cancer.


Neelum Naqvi, a breast cancer survivor, shared her experience of coping and fighting against the disease, with the audience. She mentioned in particular about her loss of hair during chemotherapy treatments and the importance of communication with other victims of breast cancer and family members.


Volunteer Services Director Aqdus Aslam urged the audience to support the campaign while stressing upon the need to spread awareness about breast cancer to help fight against disease, and the importance of volunteers in particular, since they can help reach the maximum number of people with this knowledge. app